Skip to main content
Clinical Trials/NCT03060824
NCT03060824
Completed
Not Applicable

Changes in Plasma Osmolality Related to the Use of Cardiopulmonary Bypass With Hyperosmolar Prime, an Observational Study.

Umeå University1 site in 1 country30 target enrollmentFebruary 21, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiopulmonary Bypass
Sponsor
Umeå University
Enrollment
30
Locations
1
Primary Endpoint
Changes in plasma osmolality
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

During the use of Cardiopulmonary Bypass (CPB) for cardiac surgery there is an instant mixture of the patient's blood and the fluid needed to fill the extracorporeal circuit before use. This will change the composition of the body fluids. This study aims to plot these changes in regard to particle concentration (osmolality).

Detailed Description

During the use of CPB for cardiac surgery there is an instant mixture of the patient's blood and the fluid needed to prime the extracorporeal circuit. Many studies have pointed to the benefits of using a hyperosmolar prime to counteract formation of tissue oedema. Rapid changes in osmolality may as a serious consequence lead to osmotic demyelination syndrome. At the Heart Centre of Umeå University Hospital, Sweden, there is a tradition of using a hyperosmolar prime. This study aims to explore changes in osmolality during coronary artery bypass grafting surgery by repeated measurements of osmolality and concentration shifts of sodium, glucose and urea in plasma.

Registry
clinicaltrials.gov
Start Date
February 21, 2017
End Date
December 11, 2017
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age 60-80 yr
  • New York Heart Association Functional Classification(NYHA) I-III
  • Body Surface Area(BSA) 1.8-2.5 m2

Exclusion Criteria

  • Estimated Glomerular Filtration Rate(eGFR)\<50ml/min/1,73 m2

Outcomes

Primary Outcomes

Changes in plasma osmolality

Time Frame: Before surgery; repeated during surgery and on postoperative day 1 and 2.

Repeated measurements of plasma osmolality aim to outline changes in plasma osmolality related to the use of hyperosmolar prime.

Secondary Outcomes

  • Change in osmolar gap(Before surgery; repeated during surgery and on postoperative day 1 and 2.)

Study Sites (1)

Loading locations...

Similar Trials